乌鸦传媒

Pivotal study supports safety, effectiveness of TAVR adjunct device against coronary obstruction

Valve characterized by availability of intermediate sizes among other design features

REC-CAGEFREE II is the first randomized trial on antiplatelet strategies after DCB therapy

Controversial findings of low-risk trial allowing bicuspid patients

AID strategy boosted diagnostic yield upfront

Small trial favors percutaneous approach to concomitant aortic stenosis and coronary disease

Earlier signal of noncardiovascular mortality refuted by large meta-analysis

Early results promising with DynamX bioadaptor, though traditional BRS hasn't been abandoned

First randomized trial sets the stage for larger, more definitive studies

TMVR fares at least as well as conservative treatment in observational analysis

Early study suggests role for neuroprotection from air bubbles

Comparing leaflet splitting vs conventional stenting to avoid coronary obstruction

"Like walking on the moon," researcher says of doing cases without lead aprons

Yet some growing pains remain for the Jenavalve Trilogy